CLINICAL_TRIALS
trial_result
· 2024-06-03
Clinical Trial Update: Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome [Phase 2]
Summary
Phase 2 study evaluating the efficacy, safety, and tolerability of RGH-706 in Prader-Willi Syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gedeon Richter Plc. | Conditions: Prader-Willi Syndrome | Phase 2 | Status: COMPLETED